|
USP48 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.143400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.341800E-01 |
| Normal-vs-Stage2 |
6.873000E-01 |
| Normal-vs-Stage3 |
4.163900E-02 |
| Normal-vs-Stage4 |
7.633500E-02 |
| Stage1-vs-Stage2 |
6.030200E-01 |
| Stage1-vs-Stage3 |
1.326100E-02 |
| Stage1-vs-Stage4 |
3.934000E-02 |
| Stage2-vs-Stage3 |
2.361600E-01 |
| Stage2-vs-Stage4 |
2.948800E-01 |
| Stage3-vs-Stage4 |
9.031600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.812400E-01 |
| Normal-vs-AfricanAmerican |
1.440290E-02 |
| Normal-vs-Asian |
8.769200E-01 |
| Caucasian-vs-AfricanAmerican |
3.584300E-02 |
| Caucasian-vs-Asian |
7.428000E-01 |
| AfricanAmerican-vs-Asian |
2.392800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.128960E-01 |
| Normal-vs-Female |
8.542800E-01 |
| Male-vs-Female |
3.560000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.362810E-01 |
| Normal-vs-Age(41-60Yrs) |
8.308400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.351000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.320400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.246200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.256000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.123400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.434800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.071970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.056800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.592150E-02 |
| Normal-vs-Grade 2 |
2.780200E-01 |
| Normal-vs-Grade 3 |
2.163600E-02 |
| Normal-vs-Grade 4 |
4.522100E-03 |
| Grade 1-vs-Grade 2 |
1.095600E-01 |
| Grade 1-vs-Grade 3 |
6.616600E-04 |
| Grade 1-vs-Grade 4 |
3.564700E-04 |
| Grade 2-vs-Grade 3 |
2.13379999999264E-05 |
| Grade 2-vs-Grade 4 |
1.230450E-04 |
| Grade 3-vs-Grade 4 |
3.162800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.793790E-02 |
| Normal-vs-ccB subtype |
2.784700E-03 |
| ccA subtype-vs-ccB subtype |
7.80549958001586E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.351000E-01 |
| Normal-vs-N1 |
2.800000E-02 |
| N0-vs-N1 |
1.539410E-01 |
|
|
